Advances in DNA Vaccines 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>alphaviruses||layered RNA/DNA vectors||DNA vaccines||RNA replicons||recombinant particles||tumor regression||protection against tumor challenges and infectious agents||ebola virus disease||artificial T-cell antigens||DNA vaccine constructs||computer design||gene expression||immunogenicity||DNA vaccine||mRNA vaccine||plasmid DNA||in vitro transcribed mRNA||immune responses||formulations||Cytolytic T Lymphocytes||antibodies||innate immunity||adjuvants||vaccine delivery||plasmid||cytolytic||perforin||bicistronic||HCV||HIV||IL-36||adjuvant||DNA||Zika||Epstein-Barr virus||latent proteins||LMP2||EBNA1||LMP1||HIV-1||enhancer element||circovirus||influenza||immunization||intranasal||lipid||flagellin||BCG||vaccine||rBCG||HTI||T-cell||AIDS||clinical trial||therapeutic vaccine||hepatitis C virus (HCV)||mesenchymal stem cells (MSC)||modified MSC||DNA immunization||nonstructural HCV proteins||immune response||HCV vaccine||myeloid derived suppressor cells (MDSCs)||n/a